· Principles
· Blood groups
· Compatibility testing
Grouping |
· RBCs have membrane protein antigens (Ag) · Antibodies (Ab) are produced against non-self RBC antigen after exposed · Aim of grouping is to determine ABO and RhD antigen presence on RBC |
Transfusion |
· Allogeneic transfusion only safe if recipient won’t make antibodies against donor’s antigens · Donor plasma removed from packed RBC hence donor antibodies rarely matter · O- is universal RBC donor, AB+ universal recipient · AB+ is universal plasma donor, O- universal recipient |
Compatibility requirements |
· Red cells: ABO, +/-RhD, other antibodies · Platelets: ABO, +/-RhD preferred · Plasma products: ABO |
Special considerations |
· Test valid for a few days in hospital because: o Existing titres may change o New antibodies may be formed · Some antibody-antigen interactions more important than others · RhD compatibility required if RhD- female patient of child-bearing potential |
ABO |
· Most important system · A: A antigen · B: B antigen · O: neither antigen · Incompatibility -> intravascular haemolysis · Antigen: is carbohydrate, more antigenic · Antibodies: developed soon after birth due to diet exposure; more IgM, does not cross placenta |
RhD |
· Next most important system · Incompatibility -> extravascular haemolysis · Antigen: is protein, less antigenic · Antibodies: developed only upon direct blood exposure; more IgG, does cross placenta |
Other |
· Kell, Kidd, Duffy, Lewis etc. |
Forward typing |
· Patient’s RBCs + serum solutions known to have anti-A, anti-B or anti-RhD o ABO: observe for agglutination (since IgM, pentameric) o RhD: wash away serum, add Coombs reagent, observe for agglutination (since IgG, monomeric) · Performed for ABO and RhD |
Reverse typing |
· Patient’s serum + RBC solutions known to have A Ag, B Ag or RhD A o ABO: as above o RhD: as above · Performed for ABO (i.e. double check) |
Antibody screen |
· Patient’s serum + RBC solutions known to have various RBC antigens (e.g. Kell, Kidd, Duffy) · Wash away the serum · Add Coombs reagent, observe for agglutination (since IgG, monomeric) |
Cross-match |
· Donor’s RBC + potential recipient’s serum · Mostly computer matching based on group and antibody screen · Occasionally by in vitro transfusion
·
Ensures almost 100% safety |
Feedback welcome at ketaminenightmares@gmail.com